Exor NV: A Way to Buy Ferrari at a 50% Discount?

Key Concepts

• Exor NB (EXA/XR NB) as a Discounted Ferrari Play: The core thesis revolves around Exor trading at a significant discount (60%) to its Net Asset Value (NAV), offering a potentially cheaper way to gain exposure to Ferrari (RACE).
• NAV & Valuation: Exor’s NAV is approximately €36 billion, with a current market capitalization of €15 billion. Return projections range from 10-20% based on NAV compounding and discount compression.
• Governance & Family Control: The Agnelli family maintains substantial control (effectively 50% equity), raising concerns about capital allocation and potential misalignment of incentives.
• Accounting Reclassification & Transparency: Exor’s recent transition to investment company classification under IFRS standards, with fair value accounting and audited NAV disclosures, increases transparency and comparability to Berkshire Hathaway.
• Catalysts & Risks: Key catalysts include market recognition of the discount, while risks involve Exor reducing its Ferrari stake and inherent challenges of investing in a European, family-controlled holding company.

Exor NB & Ferrari: A Comprehensive Investment Analysis

I. Historical Context & Structure (Part 1)

Exor NB (XR NB) is a multi-generational holding company founded in 1927 by Giovanni Agnelli, the founder of Fiat. Controlled by the Agnelli family (86% voting rights, 55% economic rights), it operates as both a conglomerate and a family office. A significant stake in Ferrari was acquired in the 1960s, eventually growing to 20% ownership with 30% effective control. Exor’s NAV has compounded at 13.5% annually over the last decade, and 18% annually from 2009-2024.

II. Ferrari as a Core Holding & Valuation Discrepancy (Parts 1 & 2)

Ferrari represents nearly 50% of Exor’s NAV. While the speakers previously admired Ferrari’s strong financial performance (25%+ EPS compounding, 50%+ gross margins, 11x total shareholder return since spin-off vs. MSCI World’s 3x), they found its standalone valuation (around 40x earnings) too high. The primary investment thesis centers on acquiring Ferrari exposure through Exor, effectively purchasing shares “at half price” due to the 60% discount to NAV.

III. The Discount to NAV & Return Projections (Part 2)

Exor currently trades at a 60% discount to its €36 billion NAV, resulting in a €15 billion market capitalization. This discount is considered a substantial margin of safety. Return projections, based on varying NAV compounding rates and discount compression scenarios, range from 10% (bear case: 5% NAV compounding, 50% discount) to 20% (bull case: 9% NAV compounding, 30% discount), with a base case of 16% (7% NAV compounding, 40% discount). Exor’s consistent share buybacks (nearly 3% annually since 2019) are expected to further boost per-share value.

IV. Financial Profile & Debt Structure (Part 2)

Exor’s debt is 95% fixed-rate, secured during a low-interest rate environment. Its long-term borrower rating is A- from S&P Global, considered upper medium grade. The company also pays a small dividend, not factored into the return projections.

V. Governance & Management Considerations (Part 2)

The Agnelli family’s significant control (effectively 50% equity) is acknowledged as a potential concern, typical of European companies. John Elken’s compensation (€11.3 million + €7 million from chairmanships) is viewed as excessive given his role managing family wealth. The discussion explores whether incentives are aligned with aggressive growth or primarily focused on wealth preservation.

VI. Accounting Changes & Increased Transparency (Part 2)

In 2024, Exor transitioned to investment company classification under IFRS standards. This resulted in fair value accounting for investments (impacting reported earnings) and audited NAV disclosures, increasing transparency and making Exor more comparable to Berkshire Hathaway. Proceeds from sales, acquisitions, and dividends are now classified as operating cash flows.

VII. Catalysts, Risks & Investment Strategy (Part 2)

The primary catalyst is market recognition of the discount. Key risks include Exor significantly reducing its Ferrari stake, diminishing the investment’s appeal, and the inherent challenges of investing in a European, family-controlled holding company. The proposed investment size is 5-7% of the portfolio, potentially increasing to 10%, with an exit rule to sell if Exor reduces its Ferrari stake. Recent selling pressure following Ferrari share sales presents a potential entry point.

VIII. Additional Considerations (Part 2)

Exor’s partnership with Sir Jony Ive and the presence of Guy Spier as a shareholder are viewed as positive signals. Ferrari’s ability to maintain high margins, drive revenue growth, and benefit from operating leverage is crucial to the investment thesis.

Conclusion

Exor NB presents a compelling, albeit complex, investment opportunity. The significant discount to NAV, driven primarily by its substantial Ferrari stake, offers a potentially cheaper way to gain exposure to a high-quality asset. While governance concerns and the inherent risks of investing in a family-controlled European holding company require careful consideration, the potential for substantial returns, coupled with increased transparency through recent accounting changes, makes Exor a worthy candidate for further investigation. The success of this investment hinges on Exor maintaining its Ferrari stake and the market recognizing the inherent undervaluation.